| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Dec 15, 2025 | Dec 15, 2025 | Zentalis Pharmaceuticals, Inc. | 10% Owner | Sell | 16.3 | -7,500,000 | -53.73% | ✗ | $10M |
| Nov 9, 2023 | Nov 9, 2023 | Aura Biosciences, Inc. | 10% Owner | Buy | 100.0 | +1,560,000 | 29.09% | ✗ | $14M |
| Jun 20, 2023 | Jun 20, 2023 | Zentalis Pharmaceuticals, Inc. | 10% Owner | Buy | 100.0 | +4,760,000 | 51.74% | ✗ | $107.9M |
| Dec 5, 2022 | Dec 7, 2022 | Aura Biosciences, Inc. | 10% Owner | Buy | 100.0 | +1,250,000 | 30.39% | ✗ | $15M |
| Nov 2, 2021 | Nov 4, 2021 | Aura Biosciences, Inc. | 10% Owner | Buy | 100.0 | +1,785,000 | 76.68% | ✗ | $25M |
| Mar 8, 2021 | Mar 10, 2021 | Adaptive Biotechnologies Corp | Director | Sell | 15.0 | -806,000 | -6.14% | ✗ | $32.2M |
| Jul 20, 2020 | Jul 22, 2020 | Adaptive Biotechnologies Corp | Director | Sell | 15.0 | -2,000,000 | -13.23% | ✗ | $80M |